Guardant Health (GH) Current Deferred Revenue (2017 - 2026)

Guardant Health has reported Current Deferred Revenue for 10 years, with the latest figure at $52.0 million in Q2 2026.

• Quarterly Current Deferred Revenue fell 14.33% year-over-year to $52.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $52.0 million (down 14.33% YoY) and the FY2025 annual result came in at $59.7 million, up 43.51% from the prior year.
• Current Deferred Revenue fell to $52.0 million in Q2 2026 per GH's latest filing, from $56.7 million in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $60.7 million in Q2 2025 and troughed at $10.6 million in Q1 2022.
• A 5-year average of $33.9 million and a median of $30.2 million in 2024 frame the typical range for Current Deferred Revenue.
• The sharpest annual moves came in 2024 and 2026: Current Deferred Revenue surged 134.44% in 2024, then declined 14.33% in 2026.
• Over 5 years, Current Deferred Revenue stood at $21.2 million in 2022, then increased by 8.02% to $22.9 million in 2023, then surged by 81.66% to $41.6 million in 2024, then soared by 43.51% to $59.7 million in 2025, then dropped by 12.9% to $52.0 million in 2026.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $52.0 million, $56.7 million, and $59.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.